 TEL AVIV, Israel, Sept. 01, 2022 GLOBE NEWSWIRE -- PainReform Ltd. Nasdaq: PRFX PainReform or the Company, a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that Ilan Hadar, Chief Executive Officer of PainReform, will be presenting at the H.C. Wainwright 24th Annual Global Investment Conference which is being held September 12th - 14th, 2022. The event will include virtual participation as well as in-person participation at the Lotte New York Palace Hotel in New York City. 